1. Home
  2. WKEY vs IBIO Comparison

WKEY vs IBIO Comparison

Compare WKEY & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WISeKey International Holding Ltd

WKEY

WISeKey International Holding Ltd

HOLD

Current Price

$6.68

Market Cap

83.5M

Sector

Technology

ML Signal

HOLD

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$2.20

Market Cap

72.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKEY
IBIO
Founded
1999
2008
Country
Switzerland
United States
Employees
102
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
72.2M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
WKEY
IBIO
Price
$6.68
$2.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$10.50
$4.75
AVG Volume (30 Days)
91.2K
913.6K
Earning Date
04-30-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$31.22
N/A
Revenue Next Year
$91.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.26
$0.56
52 Week High
$19.80
$3.82

Technical Indicators

Market Signals
Indicator
WKEY
IBIO
Relative Strength Index (RSI) 51.79 51.01
Support Level $6.43 $2.02
Resistance Level $6.92 $2.82
Average True Range (ATR) 0.45 0.16
MACD 0.09 0.04
Stochastic Oscillator 88.59 88.95

Price Performance

Historical Comparison
WKEY
IBIO

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: